Document:

Ex-4.1

 Exhibit 4.1 

NINTH SUPPLEMENTAL INDENTURE dated as of January 26, 2015, among Covidien International Finance S.A., a Luxembourg company (the
“Company”), Covidien Ltd., a Bermuda company (“CLTD”), Covidien plc, a public limited company incorporated under the laws of Ireland (“CPLC” and, together with CLTD, the “Current
Guarantors”), Medtronic plc, a public limited company incorporated under the laws of Ireland (“New Medtronic”), Medtronic Global Holdings SCA, a corporate partnership limited by shares (société en
commandite par actions) organized under the laws of the Grand Duchy of Luxembourg (“Medtronic Luxco” and, together with New Medtronic, the “Parent Guarantors”) and Deutsche Bank Trust Company Americas, a New
York banking corporation, as trustee (the “Trustee”). 
 W I T N E S S E T H 

WHEREAS, the Company and CLTD have heretofore executed and delivered to the Trustee an Indenture, dated as of October 22, 2007 (the
“Original Base Indenture” and, as subsequently amended by the Fifth Supplemental Indenture, the “Base Indenture”), providing for the issuance from time to time of the Company’s debentures, notes or other
evidences of indebtedness (herein and therein called the “Securities”), to be issued in one or more series as provided in the Base Indenture, and for the issuance of guarantees of the Securities; 

WHEREAS, the Company and CLTD have heretofore executed and delivered to the Trustee a first supplemental indenture dated as of
October 22, 2007 (the “First Supplemental Indenture”), providing for the issuance of $250,000,000 aggregate principal amount of 5.150% senior notes due 2010 (the “First Notes”); 

WHEREAS, the Company and CLTD have heretofore executed and delivered to the Trustee a second supplemental indenture dated as of
October 22, 2007 (the “Second Supplemental Indenture”), providing for the issuance of $500,000,000 aggregate principal amount of 5.450% senior notes due 2012 (the “Second Notes”); 

WHEREAS, the Company and CLTD have heretofore executed and delivered to the Trustee a third supplemental indenture dated as of
October 22, 2007 (the “Third Supplemental Indenture”), providing for the issuance of $1,150,000,000 aggregate principal amount of 6.000% senior notes due 2017 (the “Third Notes”); 

WHEREAS, the Company and CLTD have heretofore executed and delivered to the Trustee a fourth supplemental indenture dated as of
October 22, 2007 (the “Fourth Supplemental Indenture”), providing for the issuance of $850,000,000 aggregate principal amount of 6.550% senior notes due 2037 (the “Fourth Notes”) 

WHEREAS, the Company, CLTD and CPLC have heretofore executed and delivered to the Trustee a fifth supplemental indenture dated as of
June 4, 2009 (the “Fifth Supplemental Indenture”), providing for the addition of CPLC as an additional guarantor under the Base Indenture and the Securities, including the First Notes, the Second Notes, the Third Notes and the
Fourth Notes, and to make certain other amendments; 
 WHEREAS, the Company and the Current Guarantors have heretofore executed and
delivered to the Trustee a sixth supplemental indenture dated as of June 28, 2010 (the “Sixth Supplemental Indenture”), providing for the issuance of $500,000,000 aggregate principal amount of 1.875% senior notes due 2013,
$400,000,000 aggregate principal amount of 2.80% senior notes due 2015 and $600,000,000 aggregate principal amount of 4.20% senior notes due 2020 (collectively, the “Fifth Notes”); 

 WHEREAS, the Company and the Current Guarantors have heretofore executed and delivered to the
Trustee a seventh supplemental indenture dated as of May 30, 2012 (the “Seventh Supplemental Indenture”), providing for the issuance of $600,000,000 aggregate principal amount of 1.350% senior notes due 2015 and $650,000,000
aggregate principal amount of 3.200% senior notes due 2022 (collectively, the “Sixth Notes”); 
 WHEREAS, the Company and
the Current Guarantors have heretofore executed and delivered to the Trustee an eighth supplemental indenture dated as of May 16, 2013 (the “Eighth Supplemental Indenture” and, together with the First Supplemental Indenture,
the Second Supplemental Indenture, the Third Supplemental Indenture, the Fourth Supplemental Indenture, the Fifth Supplemental Indenture, the Sixth Supplemental Indenture and the Seventh Supplemental Indenture, the “Indenture”),
providing for the issuance of $750,000,000 aggregate principal amount of 2.950% senior notes due 2023 (the “Seventh Notes” and, together with the First Notes, the Second Notes, the Third Notes, the Fourth Notes, the Fifth Notes and
the Sixth Notes, the “Notes”); 
 WHEREAS, Section 9.01(h) of the Base Indenture permits the Company, the Current
Guarantors and the Trustee, without the consent of any Securityholder, to enter into an indenture supplemental to the Base Indenture to make any change that does not adversely affect the rights of any Securityholder of Outstanding Securities in any
material respect; 
 WHEREAS, pursuant to Section 9.01 of the Base Indenture, the Trustee is authorized to execute and deliver this
Ninth Supplemental Indenture. 
 NOW, THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the
receipt of which is hereby acknowledged, the parties mutually covenant and agree for the equal and ratable benefit of the Securityholders as follows: 

SECTION 1. Capitalized Terms. Capitalized terms used herein without definition shall have the meanings assigned to them in the Base
Indenture and the rules of construction contained in the Base Indenture will apply equally to this Ninth Supplemental Indenture. 
 SECTION
2. Definitions. For all purposes of this Ninth Supplemental Indenture, the terms defined in this Section 2 have the meanings assigned to them in this Section: 

“Parent Guaranty” means a guarantee by a Parent Guarantor pursuant to Section 3 of this Ninth Supplemental Indenture.

 “Other Guarantor” means any guarantor, other than a Parent Guarantor, of the Indenture and the Notes. 

SECTION 3. Parent Guarantee. 

(a) Each Parent Guarantor, hereby, jointly and severally, irrevocably and unconditionally guarantees, on a senior basis, for itself and its
successors and assigns, irrespective of the validity and enforceability of the Indenture or the Notes, or the obligations of the Company thereunder, that: (1) the principal of and premium, if any, and interest on the Notes, shall be promptly
paid in full when due, whether at maturity, by acceleration, redemption or otherwise, and interest on the overdue principal of and interest on the Notes, if any, if lawful, shall be promptly paid in full, all in accordance with the terms of the
Indenture and the Notes; and (2) in case of any extension of time of payment of renewal of any Notes, that same shall be promptly paid in full when due in accordance with the terms of the extension or renewal, whether a stated maturity, by
acceleration or otherwise. Failing payment by the Company when due of any amount so guaranteed for whatever reason, the Parent Guarantors shall be jointly and severally obligated to pay the same immediately. Each Parent Guarantor agrees that this is
a guarantee of payment and not a guarantee of collection. 

 (b) The Parent Guarantors hereby agree that their obligations under the Indenture and the Notes
shall be unconditional, irrespective of the validity, regulatory or enforceability of the Indenture or the Notes, the absence of any action to enforce the same, any waiver or consent by any Securityholder with respect to any provisions of the
Indenture or the Notes, the recovery of any judgment against the Company, any action to enforce the same or any other circumstance which might otherwise constitute a legal or equitable discharge or defense of a guarantor. Each Parent Guarantor
hereby waives diligence, presentment, demand of payment, filing of claims with a court in the event of insolvency or bankruptcy of the Company, any right to require a proceeding first against the Company, protest, notice and all demands whatsoever
and covenants that a Parent Guaranty shall not be discharged except by complete performance of the obligations contained in the Indenture and the Notes, or pursuant to Section 3(c) of this Ninth Supplemental Indenture. 

(c) A Parent Guaranty by a Parent Guarantor shall be automatically and unconditionally released and discharged, and such Parent Guaranty shall
thereupon terminate and be discharged and be of no further force and effect, and no further action by such Parent Guarantor, the Company or the Trustee shall be required for the release of such Parent Guarantor’s Parent Guaranty: (A) upon
the merger or consolidation of such Parent Guarantor with and into the Company, any other Parent Guarantor or any Other Guarantor that is a surviving person in such merger or consolidation, or upon the liquidation of such Parent Guarantor following
or concurrently with the transfer of all or substantially all of its assets to Company, another Parent Guarantor or any Other Guarantor (and, if applicable, any minority stockholders of such Parent Guarantor or Other Guarantor) or (B) upon the
Company exercising its legal defeasance or covenant defeasance options in accordance with the terms of the Indenture and the Notes. 

SECTION 4. Each Parent Guarantor acknowledges that it will receive direct and indirect benefits from the financing arrangements contemplated
by its Parent Guaranty, the Indenture and this Ninth Supplemental Indenture and that the guarantee and waivers made by it pursuant to its Parent Guaranty are knowingly made in contemplation of such benefits. 

SECTION 5. No past, present or future stockholder, officer, director, employee or incorporator of any Parent Guarantor shall have any
liability under the Parent Guaranty, the Indenture or this Ninth Supplemental Indenture by reason of such person’s status as stockholder, officer, director, employee or incorporator. 

SECTION 6. Relationship to Existing Base Indenture. This Ninth Supplemental Indenture is a supplemental indenture within the meaning of
the Base Indenture. The Base Indenture, as amended and supplemented by this Ninth Supplemental Indenture, is in all respects ratified, confirmed and approved and, with respect to the Notes, the Base Indenture, as amended and supplemented by this
Ninth Supplemental Indenture, shall be read, taken and construed as one and the same instrument. 
 SECTION 7. Governing Law. THIS
NINTH SUPPLEMENTAL INDENTURE WILL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK AND OF THE UNITED STATES. 

SECTION 8. Waiver of Jury Trial. EACH OF THE COMPANY, THE CURRENT GUARANTORS AND THE PARENT GUARANTORS AND THE TRUSTEE HEREBY
IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS NINTH SUPPLEMENTAL INDENTURE, ANY PARENT GUARANTY OR THE TRANSACTION CONTEMPLATED
HEREBY. 

 SECTION 9. Headings. The headings of the Sections of this Ninth Supplemental
Indenture have been inserted for convenience of reference only, are not to be considered a part of this Ninth Supplemental Indenture and shall in no way modify or restrict any of the terms or provisions hereof. 

SECTION 10. Counterparts. The parties may sign any number of copies of this Ninth Supplemental Indenture. Each signed copy shall be an
original, but all of them together represent the same agreement. The exchange of copies of this Ninth Supplemental Indenture and of signature pages by facsimile or .pdf transmission shall constitute effective execution and delivery of this Ninth
Supplemental Indenture as to the parties hereto and may be used in lieu of the original Ninth Supplemental Indenture for all purposes. Signatures of the parties hereto transmitted by facsimile or .pdf shall be deemed to be their original signatures
for all purposes. 
 SECTION 11. Trustee. The Trustee shall not be responsible in any manner whatsoever for or in the respect of the
validity or sufficiency of this Ninth Supplemental Indenture or for or in respect of the recitals contained herein, all of which recitals are made solely by the Company, the Current Guarantors and the Parent Guarantors, as the case may be. 

[Signature Page Follows] 

 IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed, all as of the
date first above written. 
  

					
	COVIDIEN INTERNATIONAL FINANCE S.A.
		
	By:	 	 /s/ Philip J. Albert

		 	Name:	 	Philip J. Albert
		 	Title:	 	Chairman of the Board

 [Supplemental Indenture Signature Page] 

 IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed, all as of the
date first above written. 
  

					
	COVIDIEN PUBLIC LIMITED COMPANY
		
	By:	 	 /s/ Gary L. Ellis

		 	Name:	 	Gary L. Ellis
		 	Title:	 	President and Chief Financial Officer

 [Supplemental Indenture Signature Page] 

 IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed, all as of the
date first above written. 
  

					
	COVIDIEN LTD.
		
	By:	 	 /s/ Gary L. Ellis

		 	Name:	 	Gary L. Ellis
		 	Title:	 	President and Chief Financial Officer

 [Supplemental Indenture Signature Page] 

 IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed, all as of the
date first above written. 
  

					
	SIGNED AND DELIVERED as a Deed	 		 	
	for and on behalf of	 		 	
	 MEDTRONIC PLC
 by its lawfully appointed
attorney
	 		 	
	 GARY L. ELLIS
 in the presence
of:
	 		 	
			
		 		 	 /s/ Gary L. Ellis

	 /s/ Althea Laska
	 		 	Signature of Attorney
	(Witness’ Signature)	 		 	
			
	 Althea Laska
	 		 	
	(Witness’ Name)	 		 	
			
	 710 Medtronic Parkway, Minneapolis, Minnesota
	 		 	
	(Witness’ Address)	 		 	
			
	 Exec. Assistant
	 		 	
	(Witness’ Occupation)	 		 	

 [Supplemental Indenture Signature Page] 

 IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed, all as of the
date first above written. 
 MEDTRONIC GLOBAL HOLDINGS S.C.A., 

as Guarantor 
 a Luxembourg corporate partnership limited by
shares (société en commandite par actions) 
 represented by 

Medtronic Global Holdings GP S.à r.l. 
 Its General
Partner, in turn acting by 
  

					
	By:	 	 /s/ Andrej Grossmann

		 	Name:	 	Andrej Grossmann
		 	Title:	 	Class A Manager
	
	AND
		
	By:	 	 /s/ Linda Harty

		 	Name:	 	Linda Harty
		 	Title:	 	Class B Manager

 IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed, all as of the
date first above written. 
  

			
	DEUTSCHE BANK TRUST COMPANY AMERICAS, as Trustee
		
	By:	 	 /s/ Carol Ng

	Name:	 	Carol Ng
	Title:	 	Vice President

  

			
		
	By:	 	 /s/ Anthony D’Amato

	Name:	 	Anthony D’Amato
	Title:	 	AssociateEX-10.1

 Exhibit 10.1 

EMPLOYMENT AGREEMENT 

This EMPLOYMENT AGREEMENT (the “Agreement”) is made on this 26th day of January, 2015, with the intent that it be effective as of
the 2nd day of February, 2015 (the “Effective Date”), by and between Kindred Healthcare Operating, Inc., a Delaware corporation (the “Company”), and Kent H. Wallace (the “Executive”). 

W I T N E S S E T H: 

WHEREAS, the Company, a wholly-owned subsidiary of Kindred Healthcare, Inc. (“Parent”), desires to employ the Executive as of and
following the Effective Date and the parties desire to provide for the terms of Executive’s employment by the Company; and 
 WHEREAS,
the Executive Compensation Committee of the Board of Directors of the Parent has determined that it is in the best interests of the Company and Parent to enter into this Agreement; 

NOW, THEREFORE, in consideration of the premises and the respective covenants and agreements contained herein, and intending to be legally
bound hereby, the Company and Executive agree as follows: 
 1. Employment. The Company hereby agrees to employ Executive and
Executive hereby agrees to be employed by the Company on the terms and conditions herein set forth. The initial term of this Agreement shall be for a one-year period commencing on the Effective Date. The term shall be automatically extended by one
additional day for each day beyond the Effective Date that the Executive remains employed by the Company until such time as the Company elects to cease such extension by giving written notice of such election to the Executive (the “Term”).
In such event, the Agreement shall terminate on the first anniversary of the effective date of such election notice. 
 2. Duties.
Executive will be engaged by the Company as Executive Vice President and Chief Operating Officer. 
 3. Extent of Services.
Executive, subject to the direction and control of the Chief Executive Officer of the Company and the Board of Directors of Parent (the “Board”), shall have the power and authority commensurate with his executive status and necessary to
perform his duties hereunder. During the Term, Executive shall devote substantially all of his working time, attention, labor, skill and energies to the business of the Company, and shall not, without the consent of the Company, which shall not be
unreasonably withheld, be actively engaged in any other business activity, whether or not such business activity is pursued for gain, profit or other pecuniary advantage. Notwithstanding the foregoing, it shall not be a violation of this Agreement
for Executive to (a) act or serve as a director, trustee, committee member or principal of any type of civic or charitable organization as long as such activities are disclosed in advance in writing to the Board, (b) engage in real estate
investment activities, and (c) purchase 

 
or own less than five percent (5%) of the publicly traded securities of any corporation; provided that, such ownership represents a passive investment and that the Executive is not a
controlling person of, or a member of a group that controls, such corporation; provided further that, the activities described in clauses (a), (b), and (c) do not interfere with or otherwise adversely affect the performance of
Employee’s responsibilities under this Agreement and do not compete with the business activities of the Company. Company hereby consents to Executive’s current service as a director of Imaging Advantage, LLC. 

4. Compensation. As compensation for services hereunder rendered, Executive shall receive during the Term: 

(a) A base salary (“Base Salary”) of $700,000 per year payable in equal installments in accordance with the
Company’s normal payroll procedures. Executive may receive increases in his Base Salary from time to time, as approved by the Board. 

(b) In addition to Base Salary, Executive shall be entitled to receive bonuses and other incentive compensation as the Board
may approve from time to time, including participation in the Company’s annual short-term incentive compensation plan and long-term incentive compensation plan, in accordance with the terms and conditions of such plans as may be in effect from
time to time, subject to the following: 
 (1) For 2015, the Executive’s target bonus under the short-term incentive
plan shall be 80% of Base Salary; and 
 (2) For 2015, the Executive’s target bonus under the long-term incentive plan
shall be 60% of Base Salary. 
 Payments under this Section 4(b) shall be made in accordance with the short-term incentive plan and
long-term incentive plan, as applicable; provided that such payments will be made within the “short-term deferral” period under Section 409A of the Code. 

(c) Within sixty (60) days following the Effective Date, the Company shall pay to the Executive a one-time lump-sum cash
payment of $50,000. Within sixty (60) days following the one-year anniversary of the Effective Date, the Company shall pay to the Executive a second one-time lump-sum cash payment of $50,000 (unless the Executive’s employment with the
Company shall have been terminated prior to the date of such payment). 
 (d) At a meeting of the Board to take place on or
prior to the Effective Date (or an action by written consent in lieu thereof), the Executive Compensation Committee of the Board will consider a one-time grant of restricted stock with a grant date of the Effective Date and with a grant date fair
value, as reasonably determined by the Executive Compensation Committee, equal to $1,000,000, which shall be governed by the terms and conditions of the Kindred Healthcare, Inc. 2011 Stock Incentive Plan, Amended and Restated, and the applicable
award agreement related thereto; provided, however, that such award agreement shall provide that such restricted stock shall vest in equal annual installments on each of the first three anniversaries of the Effective Date. 

  
 2 

 5. Benefits. 

(a) Executive shall be entitled to participate in any and all pension benefit, welfare benefit (including, without limitation,
medical, dental, disability and group life insurance coverages) and fringe benefit plans from time to time in effect for officers of the Company and its affiliates. 

(b) Executive shall be entitled to participate in such bonus, stock option, or other incentive compensation plans of the
Company and its affiliates in effect from time to time for officers of the Company. Subject to share availability, following the first anniversary of the Effective Date, the Company will recommend to the Executive Compensation Committee that
Executive receive annual equity grants in amounts which may vary based upon market total direct compensation, internal pay equity and individual performance but which are currently expected to have a grant date fair value, as reasonably determined
by the Executive Compensation Committee, of approximately $735,000, which may be in the form of restricted stock, restricted stock units, performance stock units or similar awards that will, in each case, be subject to the terms and conditions
(including, without limitation, vesting) of the Kindred Healthcare, Inc. 2011 Stock Incentive Plan, Amended and Restated, and the applicable award agreement related thereto. 

(c) Executive shall be entitled to paid time off each year, subject to the Company’s policies, as in effect from time to
time for the Company’s executive officers. Executive shall schedule the timing of such vacations in a reasonable manner. Executive also may be entitled to such other leave, with or without compensation, as shall be mutually agreed by the
Company and Executive. 
 (d) Executive may incur reasonable expenses for promoting the Company’s business, including
expenses for entertainment, travel and similar items. The Company shall reimburse Executive for all such reasonable expenses in accordance with the Company’s reimbursement policies and procedures, as may be in effect from time to time. 

(e) The Company shall reimburse all reasonable travel and relocation expenses incurred by Executive in accordance with the
Company’s Vice President Relocation Policy. In the event Executive voluntarily terminates his employment with the Company without Good Reason within one year from the Effective Date, Executive will reimburse the Company for the pro rata amount
of Executive’s relocation expenses and other amounts paid under the Company’s Vice President Relocation Policy and/or this Section 5(e). 

(f) The Company shall reimburse all reasonable attorneys’ fees incurred by Executive in connection with the negotiation of
this Agreement; provided, that such amounts shall not exceed fifteen thousand dollars ($15,000). 

  
 3 

 6. Termination of Employment. 

(a) Death or Disability. Executive’s employment shall terminate automatically upon Executive’s death during
the Term. If the Company determines in good faith that the Disability of Executive has occurred during the Term (pursuant to the definition of Disability set forth below) it may give to Executive written notice of its intention to terminate
Executive’s employment. In such event, Executive’s employment with the Company shall terminate effective on the thirtieth (30th) day after receipt of such notice by Executive (the “Disability Effective Date”), provided that,
within the thirty (30) days after such receipt, Executive shall not have returned to full-time performance of Executive’s duties. For purposes of this Agreement, “Disability” shall mean Executive’s absence from his full-time
duties hereunder for a period of ninety (90) days due to disability as defined in the Company’s long-term disability plan as in effect from time to time. 

(b) Cause. The Company may terminate Executive’s employment during the Term for Cause. For purposes of this
Agreement, “Cause” shall mean the Executive’s (i) conviction of or plea of nolo contendere to a crime involving moral turpitude; (ii) breach or violation of the representations made in Section 14 of this
Agreement; or (iii) willful and material breach by Executive of his duties and responsibilities, which is committed in bad faith or without reasonable belief that such breaching conduct is in the best interests of the Company and its
affiliates, but with respect to (iii) only if the Board adopts a resolution by a vote of at least seventy-five percent (75%) of its members so finding after giving the Executive and his attorney an opportunity to be heard by the Board and
a reasonable opportunity of not less than thirty (30) days to remedy or correct the purported breaching conduct. Any act, or failure to act, based upon authority given pursuant to a resolution duly adopted by the Board or based upon advice of
counsel for the Company shall be conclusively presumed to be done, or omitted to be done, by Executive in good faith and in the best interests of the Company. 

(c) Good Reason. Executive’s employment may be terminated during the Term by Executive for Good Reason. “Good
Reason” shall exist upon the occurrence, without Executive’s express written consent, of any of the following events: 

(i) a material adverse change in Executive’s authority, duties or responsibilities (including, without limitation, the
Company assigning to Executive duties of a substantially nonexecutive or nonmanagerial nature) (other than any such change directly attributable to the fact that the Company is no longer publicly owned); 

  
 4 

 (ii) the Company shall materially reduce the Base Salary set forth in
Section 4(a) hereof or Executive’s annual bonus opportunity set forth in Section 4(b) hereof; 
 (iii) the
Executive Compensation Committee of the Board shall fail to approve the grant to Executive of restricted stock described in Section 4(d) hereof; 

(iv) the Company shall require Executive to relocate Executive’s principal business office more than 30 miles from the
location of the Company’s current principal business office (680 S. 4th Street, Louisville, KY 40202); 
 (v) a material
breach by the Company of this Agreement; or 
 (vi) the Company shall refuse or fail to renew this Agreement as provided in
Section 1. 
 For purposes of this Agreement, “Good Reason” shall not exist until after Executive has given
the Company notice of the applicable event within ninety (90) days of the initial occurrence of such event and which is not remedied within thirty (30) days after receipt of written notice from Executive listing such claimed event and
setting forth Executive’s intention to terminate employment if not remedied; provided, that if the specified event cannot reasonably be remedied within such thirty (30) day period and the Company commences reasonable steps within
such thirty (30) day period to remedy such event and diligently continues such steps thereafter until a remedy is effected, such event shall not constitute “Good Reason” provided that such event is remedied within sixty (60) days
after receipt of such written notice. 
 (d) Notice of Termination. Any termination by the Company for Cause, or by
Executive for Good Reason, shall be communicated by Notice of Termination given in accordance with this Agreement. For purposes of this Agreement, a “Notice of Termination” means a written notice which (i) indicates the specific
termination provision in this Agreement relied upon, (ii) sets forth in reasonable detail the facts and circumstances claimed to provide a basis for termination of Executive’s employment under the provision so indicated and
(iii) specifies the intended termination date (which date, in the case of a termination for Good Reason, shall be not more than thirty days after the giving of such notice). The failure by Executive or the Company to set forth in the Notice of
Termination any fact or circumstance which contributes to a showing of Good Reason or Cause shall not waive any right of Executive or the Company, respectively, hereunder or preclude Executive or the Company, respectively, from asserting such fact
or circumstance in enforcing Executive’s or the Company’s rights hereunder. 
 (e) Date of Termination.
“Date of Termination” means (i) if Executive’s employment is terminated by the Company for Cause, or by Executive for Good Reason, the later of the date specified in the Notice of Termination or the date that is one day after the
last day of any applicable cure period, (ii) if Executive’s employment is terminated by 

  
 5 

 
the Company other than for Cause or Disability, or Executive resigns without Good Reason, the Date of Termination shall be the date on which the Company or Executive notified Executive or the
Company, respectively, of such termination and (iii) if Executive’s employment is terminated by reason of death or Disability, the Date of Termination shall be the date of death of Executive or the Disability Effective Date, as the case
may be. 
 7. Obligations of the Company Upon Termination. Following any termination of Executive’s employment hereunder, the
Company shall pay Executive his Base Salary through the Date of Termination and any amounts owed to Executive pursuant to the terms and conditions of the benefit plans and programs of the Company at the time such payments are due. In addition,
subject to Section 7(e) hereof and the conditions set forth below, Executive shall be entitled to the following additional payments: 

(a) Death or Disability. If, during the Term, Executive’s employment shall terminate by reason of Executive’s
death or Disability, the Company shall pay to Executive (or his designated beneficiary or estate, as the case may be) the prorated portion of any Target Bonus (as defined below) Executive would have received for the year of termination of
employment. Such amount shall be paid on the date when such amounts would otherwise have been payable to the Executive if Executive’s employment with the Company had not terminated as determined in accordance with the terms and conditions of
the applicable short-term incentive plan of the Company; provided that such payment will be made within the “short-term deferral” period under Section 409A of the Code. 

For purposes of this Agreement: “Target Bonus” shall mean the full amount of the targeted annual short-term incentive
bonus that would be payable to the Executive, assuming the targeted performance criteria on which such annual short-term incentive bonus is based were deemed to be satisfied, in respect of services for the calendar year in which the date in question
occurs. 
 (b) Good Reason; Other than for Cause. If, during the Term, the Company shall terminate Executive’s
employment other than for Cause (but not for Disability), or the Executive shall terminate his employment for Good Reason: 

(1) In satisfaction of the annual bonus Executive would otherwise be eligible to receive under the short-term incentive plan in
respect of the calendar year in which the Date of Termination occurs, the Company shall pay to Executive an amount equal to the product of (i) the annual bonus, if any, to which the Executive would have been entitled for the year in which the
Date of Termination occurs had Executive’s employment with the Company not been terminated, as determined in accordance with the terms and conditions of the applicable short-term incentive plan of the Company as provided in Section 4(b)
hereof, and (ii) a fraction, the numerator of which is the number of days in the period beginning on the first day of the calendar year in which the Date of 

  
 6 

 
Termination occurs and ending on the Date of Termination and the denominator of which is 365. Such amount shall be paid on the date when such amounts would otherwise have been payable to the
Executive if Executive’s employment with the Company had not terminated as determined in accordance with the terms and conditions of the applicable short-term incentive plan of the Company. 

(2) Within fourteen (14) days following Executive’s Date of Termination, the Company shall pay to Executive a cash
severance payment in an amount equal to 1.5 times the sum of the Executive’s Base Salary and Target Bonus as of the Date of Termination. 

(3) For a period of eighteen (18) months following the Date of Termination (the “Benefit Continuation Period”),
the Executive shall be treated as if he had continued to be an Executive for all purposes under the Company’s health insurance plan and dental insurance plan; or if the Executive is prohibited from participating in such plans, the Company shall
otherwise provide such benefits. Executive shall be responsible for any employee contributions for such insurance coverage. Following the Benefit Continuation Period, the Executive shall be entitled to receive continuation coverage under Part 6 of
Title I or ERISA (“COBRA Benefits”) by treating the end of this period as the applicable qualifying event (i.e., as a termination of employment) for purposes of ERISA Section 603(2)) and with the concurrent loss of coverage occurring
on the same date, to the extent allowed by applicable law. 
 (4) For the Benefit Continuation Period, Company shall maintain
in force, at its expense, the Executive’s life insurance in effect under the Company’s voluntary life insurance benefit plan as of the Date of Termination. Executive shall be responsible for any employee contributions for such insurance
coverage. For purposes of clarification, the portion of the premiums in respect of such voluntary life insurance for which Executive and Company are responsible, respectively, shall be the same as the portion for which Company and Executive are
responsible, respectively, immediately prior to the Date of Termination. 
 (5) For the Benefit Continuation Period, the
Company shall provide short-term and long-term disability insurance benefits to Executive equivalent to the coverage that the Executive would have had if he had remained employed under the disability insurance plans applicable to Executive on the
Date of Termination. Executive shall be responsible for any employee contributions for such insurance coverage. Should Executive become disabled during such period, Executive shall be entitled to receive such benefits, and for such duration, as the
applicable plan provides. For purposes of clarification, the portion of the premiums in respect of such short-term and long-term disability benefits for which Executive and Company are responsible, respectively, shall be the same as the portion for
which Executive and Company are responsible, respectively, immediately prior to the Date of Termination. 

  
 7 

 (6) Within fifteen (15) days after the Date of Termination, the Company
shall pay to Executive a cash payment in an amount, if any, necessary to compensate Executive for the Executive’s unvested interests under the Company’s retirement savings plan which are forfeited by Executive in connection with the
termination of Executive’s employment. 
 (7) Company may adopt such amendments to its executive benefit plans, if any,
as are necessary to effectuate the provisions of this Agreement. 
 (8) Any outstanding unvested stock options, stock
performance units or similar equity awards (other than restricted stock awards) held by Executive on the Date of Termination shall continue to vest in accordance with their original terms (including any related performance measures) for the duration
of the Benefit Continuation Period as if Executive had remained an employee of the Company through the end of such period and any such stock option, stock performance unit or other equity award (other than restricted stock awards) that has not
vested as of the conclusion of such period shall be immediately cancelled and forfeited as of such date. In addition, Executive shall have the right to continue to exercise any outstanding vested stock options held by Executive during the Benefit
Continuation Period; provided that in no event shall Executive be entitled to exercise any such option beyond the original expiration date of such option. Any outstanding restricted stock award held by Executive as of the Date of Termination that
would have vested during the Benefit Continuation Period had Executive remained an employee of the Company through the end of such period shall be immediately vested as of the Date of Termination and any restricted stock award that would not have
vested as of the conclusion of such period shall be immediately cancelled and forfeited as of such date. 
 (9)
Notwithstanding anything in this Agreement to the contrary, in no event shall the provision of in-kind benefits pursuant to this Section 7 during any taxable year of Executive affect the provision of in-kind benefits pursuant to this
Section 7 in any other taxable year of Executive. 
 (c) Cause; Other than for Good Reason. If Executive’s
employment shall be terminated for Cause or Executive terminates employment without Good Reason (and other than due to such Executive’s death) during the Term, this Agreement shall terminate without further additional obligations to Executive
under this Agreement. 
 (d) Death after Termination. In the event of the death of Executive during the period
Executive is receiving payments pursuant to this Agreement, Executive’s designated beneficiary shall be entitled to receive the balance of the payments; or in the event of no designated beneficiary, the remaining payments shall be made to
Executive’s estate. 

  
 8 

 (e) General Release of Claims. Notwithstanding anything herein to the
contrary, all amounts payable pursuant to this Section 7 are subject to the condition that Executive has delivered to the Company an executed copy of an irrevocable general release of claims in a form satisfactory to the Company within the
sixty (60) day period immediately following the Executive’s separation from service (the “Release Period”). Any payment that otherwise would be made prior to Executive’s delivery of such executed release pursuant to this
Section 7 shall be paid on the first business day following the conclusion of the Release Period; provided that in-kind benefits provided pursuant to subsections (b)(3), (4) and (5) of this Section 7 shall continue in effect
after separation from service pending the execution and delivery of such release for a period not to exceed sixty (60) days; provided further that if such release is not executed and delivered within such sixty (60) day period, Executive
shall reimburse the Company for the full cost of coverage during such period. 
 (f) Six Month Delay for Specified
Employees. Notwithstanding anything herein to the contrary, if at the time of Executive’s separation from service Executive is a “specified employee” as defined in Section 409A of the Internal Revenue Code of 1986, as amended
and the regulations promulgated thereunder (the “Code”) and the deferral of the payment payable pursuant to Section 7(b)(2) is necessary in order to prevent any accelerated or additional tax under Section 409A of the Code, then
the payment to which Executive would otherwise be entitled during the first six (6) months following his separation from service shall be deferred and accumulated (without any reduction in such payment ultimately paid to Executive) for a period
of six (6) months from the date of separation from service and paid in a lump sum on the first day of the seventh (7th) month following such separation from service (or, if earlier, the date of Executive’s death), together with
interest during such period at a rate computed by adding 2.00% to the Prime Rate as published in the Money Rates section of the Wall Street Journal, or other equivalent publication if the Wall Street Journal no longer publishes such information, on
the first publication date of the Wall Street Journal or equivalent publication after the date of Executive’s separation from service (provided that if more than one such Prime Rate is published on any given day, the highest of such published
rates shall be used). 
 8. Disputes. Any dispute or controversy arising under, out of, or in connection with this Agreement shall,
at the election and upon written demand of either party, be finally determined and settled by binding arbitration in the City of Louisville, Kentucky, in accordance with the Labor Arbitration rules and procedures of the American Arbitration
Association, and judgment upon the award may be entered in any court having jurisdiction thereof. The Company shall pay all costs of the arbitration and all reasonable attorneys’ and accountants’ fees of the Executive in connection
therewith, including any litigation to enforce any arbitration award. 

  
 9 

 9. Successors. 

(a) This Agreement is personal to Executive and without the prior written consent of the Company shall not be assignable by
Executive otherwise than by will or the laws of descent and distribution. This Agreement shall inure to the benefit of and be enforceable by Executive’s legal representatives. 

(b) This Agreement shall inure to the benefit of and be binding upon the Company and its successors and assigns. 

(c) The Company shall require any successor (whether direct or indirect, by purchase, merger, consolidation or otherwise) to
all or substantially all of the business and/or assets of the Company, or any business of the Company for which Executive’s services are principally performed, to assume expressly and agree to perform this Agreement in the same manner and to
the same extent that the Company would be required to perform it if no such succession had taken place. As used this Agreement, “Company” shall mean the Company as hereinbefore defined and any successor to its business and/or assets as
aforesaid which assumes and agrees to perform this Agreement by operation of law, or otherwise. 
 10. Other Severance Benefits.
Executive hereby agrees that in consideration for the payments to be received under Section 7(b) of this Agreement, Executive waives any and all rights to any payments or benefits under any severance plans or arrangements of the Company or
their respective affiliates that specifically provide for severance payments, other than the Change in Control Severance Agreement between the Company and Executive dated on or about the date hereof (the “Change in Control Severance
Agreement”); provided that any payments payable to Executive under Section 7(b) hereof (except for health, life and disability insurance coverage) shall be offset by any payments payable under the Change in Control Severance
Agreement. 
 11. Withholding. All payments to be made to Executive hereunder will be subject to all applicable required withholding
of taxes. 
 12. Non-solicitation. During the Term and for a period of one year thereafter (collectively, the “Non-solicitation
Period”), Executive shall not directly or indirectly, individually or on behalf of any person other than the Company, aid or endeavor to solicit or induce any of the Company’s or its affiliates’ employees to leave their employment
with the Company or such affiliates in order to accept employment with Executive or any other person, corporation, limited liability company, partnership, sole proprietorship or other entity; provided, however, that the foregoing shall not restrict
Executive or any other person from conducting general solicitations or advertisements not directed specifically at employees of the Company or its affiliates, or from employing any employee who responds to any such general solicitation or
advertisement or who otherwise initiates a request for employment. If the restrictions set forth in this section would otherwise be determined to be invalid or unenforceable by a court of competent jurisdiction, the parties intend and agree that
such court shall exercise its discretion in reforming the provisions of this Agreement to the end that Executive will be subject to a non-solicitation covenant which is reasonable under the circumstances and enforceable by the

  
 10 

 
Company. It is agreed that no adequate remedy at law exists for the parties for violation of this section and that this section may be enforced by any equitable remedy, including specific
performance and injunction, without limiting the right of the Company to proceed at law to obtain such relief as may be available to it. The running of the Non-solicitation Period shall be tolled for any period of time during which Executive is in
violation of any covenant contained herein, for any reason whatsoever. 
 13. Confidential Information. At no time shall Executive
divulge, furnish or make accessible to anyone any confidential or proprietary knowledge or information about the Parent, Company or any of their affiliates including, without limitation, any confidential or proprietary information concerning the
operations, plans or methods of the Company (except as required by law or order of court or other governmental agency) or any of the employees, clients, patients, customers or suppliers of the Parent or Company or any of their affiliates. For
purposes of this Section 13, “confidential or proprietary information” shall mean any information, whether in writing or disclosed orally to Executive, which is not generally available to the public. 

14. Prior Relationships. Executive hereby represents to the Company that his acceptance of this Agreement has not breached and his
performance of his duties under this Agreement will not breach any other agreement to which Executive is party, nor violate any obligation of confidentiality, non-disclosure or non-competition that Executive has with any other person or entity,
including without limitation any prior employer. To the extent Executive is subject to any obligation of confidentiality, non-disclosure or non-competition with any prior employer or other person or entity, Executive hereby represents to the Company
that (i) Executive’s compliance with such obligation of confidentiality, non-disclosure or non-competition will not interfere with or impede Executive’s performance of his duties under this Agreement, and (ii) Executive will
observe all applicable obligations of such agreement and will not use for the Company’s benefit or disclose to the Company any confidential information belonging to such prior employer or other person or entity. Furthermore, the Company
acknowledges that Executive has provided to the Company a copy of his employment agreement with his former employer, RegionalCare Hospital Partners, Inc., and the Executive has represented to the Company that the business of the Company and the
anticipated duties of Executive under this Agreement, as each have been described to the Executive by the Company, will not result in a breach of Executive’s obligations under such former employment agreement. 

15. No Mitigation. Executive shall have no duty to mitigate his damages by seeking other employment and, should Executive actually
receive compensation from any such other employment, the payments required hereunder (including, without limitation, the provision of in-kind benefits provided under Section 7(b) hereof) shall not be reduced or offset by any such compensation.
Further, the Company’s and Parent’s obligations to make any payments hereunder shall not be subject to or affected by any setoff, counterclaims or defenses which the Company or Parent may have against Executive or others. 

  
 11 

 16. Notices. Any notice required or permitted to be given under this Agreement shall be in
writing and shall be deemed to have been duly given when delivered or sent by telephone facsimile transmission, personal or overnight couriers, or registered mail with confirmation or receipt, addressed as follows: 

If to Executive: 
 Kent H.
Wallace 
 at the address on file with the Company 

If to Company: 
 Kindred
Healthcare Operating, Inc. 
 680 South Fourth Street 

Louisville, KY 40202 
 Attn:
General Counsel 
 17. Waiver of Breach and Severability. The waiver by either party of a breach of any provision of this Agreement
by the other party shall not operate or be construed as a waiver of any subsequent breach by either party. In the event any provision of this Agreement is found to be invalid or unenforceable, it may be severed from the Agreement and the remaining
provisions of the Agreement shall continue to be binding and effective. 
 18. Entire Agreement; Amendment. This instrument contains
the entire agreement of the parties with respect to the subject matter hereof and supersedes all prior agreements, promises, covenants, arrangements, communications, representations and warranties between them, whether written or oral with respect
to the subject matter hereof. No provisions of this Agreement may be modified, waived or discharged unless such modification, waiver or discharge is agreed to in writing signed by Executive and such officer of the Company specifically designated by
the Board. 
 19. Governing Law. This Agreement shall be construed in accordance with and governed by the laws of the State of
Delaware. 
 20. Headings. The headings in this Agreement are for convenience only and shall not be used to interpret or construe its
provisions. 
 21. Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an
original but all of which together shall constitute one and the same instrument. 
 22. Section 409A. 

(a) The intent of the parties is that payments and benefits under this Agreement comply with or otherwise be exempt from Section 409A of
the Code and the regulations and guidance promulgated thereunder and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted either to be exempt from or in compliance therewith. 

  
 12 

 (b) For purposes of Section 409A of the Code, (i) Executive may not, directly or
indirectly, designate the calendar year of any payment; (ii) no acceleration of the time and form of payment of any nonqualified deferred compensation to Executive or any portion thereof, shall be permitted; and (iii) each payment in a
series of payments hereunder shall be deemed to be a separate payment for purposes of Section 409A. 
 (c) For purposes of
Section 409A of the Code, your right to receive any installment payment pursuant to this Agreement will be treated as a right to receive a series of separate and distinct payments. 

(d) To the extent that any right to reimbursement of expenses or payment of any benefit in-kind under this Agreement may constitute
nonqualified deferred compensation (within the meaning of Section 409A of the Code), (i) any such expense reimbursement shall be made by the Company no later than the last day of the taxable year following the taxable year in which such
expense was incurred by Executive, (ii) the right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit, and (iii) the amount of expenses eligible for reimbursement or in-kind benefits
provided during any taxable year shall not affect the expenses eligible for reimbursement or in-kind benefits to be provided in any other taxable year; provided, that the foregoing clause shall not be violated with regard to expenses reimbursed
under any arrangement covered by Section 105(b) of the Code solely because such expenses are subject to a limit related to the period the arrangement is in effect. 

(e) A termination of employment shall not be deemed to have occurred for purposes of any provision of this Agreement providing for the payment
of “deferred compensation” (as such term is defined in Section 409A of the Code) upon or following termination of employment unless such termination of employment is also a “separation from service” from the Company within
the meaning of Section 409A and Treasury Regulation 1.409A-1(h) and, for purposes of any such provision of this Agreement, references to a “termination of employment” or any similar term or phrase shall mean “separation from
service.” 
 (f) If any provision of this Agreement (or any award of compensation or benefits provided under this Agreement) would
cause Executive to incur any additional tax or interest under Section 409A of the Code, the Company shall reform such provision to comply with 409A and agrees to maintain, to the maximum extent practicable without violating 409A of the Code,
the original intent and economic benefit to Executive of the applicable provision; provided that nothing herein shall require the Company to provide Executive with any gross-up for any tax, interest or penalty incurred by Executive under
Section 409A of the Code. Furthermore, notwithstanding anything herein to the contrary, no payment or benefit payable under this Agreement shall be required to be paid or provided in any calendar year if the payment of such payment or benefit
would constitute an impermissible acceleration under Section 409A of the Code and the transition guidance thereunder and such payment shall instead be paid as soon as practicable in the next calendar year, without interest. 

[Remainder of page is intentionally blank. Signature page follows.] 

  
 13 

 IN WITNESS WHEREOF, the parties have executed this Employment Agreement as of the date first
above written. 
  

			
	KINDRED HEALTHCARE OPERATING, INC.
		
	By:		 /s/ Paul J. Diaz

			Paul J. Diaz
			Chief Executive Officer
	
	Solely for the purpose of Section 7
	
	KINDRED HEALTHCARE, INC.
		
	By:		 /s/ Paul J. Diaz

			Paul J. Diaz
			Chief Executive Officer
	
	 /s/ Kent H. Wallace

	KENT H. WALLACE

  
 14

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00239-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00239-of-00352.parquet"}]]